| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.007 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.008 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.01 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.01 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |